Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5803)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 24, 2021 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Asghar K, Farooq A, Zulfiqar B, Loya A. Review of 10 years of research on breast cancer patients: Focus on indoleamine 2,3-dioxygenase. World J Clin Oncol 2021; 12(6): 429-436 [PMID: 34189067 DOI: 10.5306/wjco.v12.i6.429] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v12/i6/429.htm |
| Number | Citing Articles |
| 1 |
Pratyasha Sarangi. Role of indoleamine 2, 3-dioxygenase 1 in immunosuppression of breast cancer. Cancer Pathogenesis and Therapy 2023; doi: 10.1016/j.cpt.2023.11.001
|
| 2 |
Parviz Azimnasab-sorkhabi, Maryam Soltani-asl, Túlio Teruo Yoshinaga, Maria Lucia Zaidan Dagli, Cristina de Oliveira Massoco, Jose Roberto Kfoury Junior. Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment. Molecular Biology Reports 2023; 50(7): 6133 doi: 10.1007/s11033-023-08469-3
|
| 3 |
Yinan Ding, Luhong Wang, Han Li, Fengqin Miao, Zhiyuan Zhang, Chunmei Hu, Weiping Yu, Qiusha Tang, Guoliang Shao. Application of lipid nanovesicle drug delivery system in cancer immunotherapy. Journal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01429-2
|
| 4 |
Hua Yang, Yongjun Liu. RETRACTED: Kinesin Family Member 2A Serves as a Potential Biomarker Reflecting More Frequent Lymph Node Metastasis and Tumor Recurrence Risk in Basal-Like Breast Cancer Patients. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.889294
|
| 5 |
Parviz Azimnasab-sorkhabi, Maryam Soltani-asl, Túlio Teruo Yoshinaga, Cristina de Oliveira Massoco, Jose´ Roberto Kfoury Junior. IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells. Immunologic Research 2023; 71(5): 679 doi: 10.1007/s12026-023-09378-0
|
| 6 |
Parviz Azimnasab-sorkhabi, Maryam Soltani-asl, Mohammad Soleiman Ekhtiyari, Jose Roberto Kfoury Junior. Landscape of unconventional γδ T cell subsets in cancer. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09267-1
|